HENNIG Arzneimittel is a mid-sized family-owned German pharmaceutical company based near Frankfurt with 120 years of grown experience. Its success is based upon four main pillars : HENNIG Arzneimittel offers proprietary drugs to the German market in the indication vertigo and disturbances of equilibrium where it is market leader. Besides this HENNIG Arzneimittel manufactures and offers a broad range of generics - among these all generically available antivertigo products. Further core areas regard cardiovascular, metabolism, pain, neurologic and psychiatric products. A rapidly growing range of over-the-counter drugs, devices and food supplements is complementing HENNIG's product portfolio, strengthening its consumer orientation. The fourth pillar is contract manufacturing and contract development services, both for pharmaceuticals and food supplements, with a special focus upon complex solid dosage forms for modified release. Technologies include tableting, coating, dry and wet granulation, extrusion, pelletising, dry-coated tablets and capsule filling, as well as blistering and secondary packaging. The equipment allows easy scale-up from lab scale to industrial scale. HENNIG Arzneimittel offers customer-specific services, ranging from feasability studies up to full service. HENNIG's Team is composed of about 320 employees, among them are about 90 sales reps.